SMN2 pre-mRNA drugs for Spinal Muscular Atrophy
2 tracked SMN2 pre-mRNA drugs in the Spinal Muscular Atrophy race. The class explanation lives on the SMN2 pre-mRNA page; the full indication pipeline across every mechanism is on the Spinal Muscular Atrophy page.
2 approved / phase 4
Head-to-head evidence: Nusinersen vs Risdiplam (Evrysdi)